PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22119644-3	2012	In the current study, lobeline, which interacts with proteins in dopaminergic presynaptic terminals, was evaluated for its ability to attenuate neonatal ethanol-induced locomotor hyperactivity and alterations in dopamine transporter (DAT) function in striatum and prefrontal cortex (PFC).	Lobeline	22-30	solute carrier family 6 member 3	Rattus norvegicus	212-232	
22119644-3	2012	In the current study, lobeline, which interacts with proteins in dopaminergic presynaptic terminals, was evaluated for its ability to attenuate neonatal ethanol-induced locomotor hyperactivity and alterations in dopamine transporter (DAT) function in striatum and prefrontal cortex (PFC).	Lobeline	22-30	solute carrier family 6 member 3	Rattus norvegicus	234-237	
22119644-12	2012	Thus, lobeline and methylphenidate differentially altered DAT function following neonatal ethanol exposure.	Lobeline	6-14	solute carrier family 6 member 3	Rattus norvegicus	58-61	
27105955-8	2016	In contrast, lobeline, the most thoroughly investigated Lobelia alkaloid, is an alpha4beta2-nicAchR antagonist, a poor free radical scavenger, and is a less potent DAT inhibitor.	Lobeline	13-21	solute carrier family 6 member 3	Rattus norvegicus	164-167	
24484975-5	2014	Defunctionalized, unsaturated lobeline analog, meso-transdiene (MTD), exhibited lobeline-like in vitro pharmacology, lacked nAChR affinity, but exhibited high affinity for DAT, suggesting potential abuse liability.	Lobeline	30-38	solute carrier family 6 member 3	Rattus norvegicus	172-175